Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11060-021-03851-2.pdf
Reference33 articles.
1. Burkhardt JK, Riina HA, Shin BJ, Moliterno JA, Hofstetter CP, Boockvar JA (2011) Intra-arterial chemotherapy for malignant gliomas: a critical analysis. Interv Neuroradiol 17(3):286–295
2. Carson KA, Grossman SA, Fisher JD, Shaw EG (2007) Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol 25(18):2601–2606
3. Boockvar JA, Tsiouris AJ, Hofstetter CP et al (2011) Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. J Neurosurg 114(3):624–632
4. Theodotou C, Shah AH, Hayes S et al (2014) The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma. Br J Neurosurg 28(4):438–446
5. Lesniak WG, Chu C, Jablonska A et al (2019) A distinct advantage to intraarterial delivery of (89)Zr-Bevacizumab in PET imaging of mice with and without osmotic opening of the blood-brain barrier. J Nucl Med 60(5):617–622
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Endovascular surgical neuro-oncology: advancing a new subspecialty;Journal of Neuro-Oncology;2024-09-02
2. Super selective intra-arterial cerebral infusion (SSIACI) for newly diagnosed and recurrent glioblastoma;Journal of the Pakistan Medical Association;2024-06-28
3. Emerging Therapies for Glioblastoma;Cancers;2024-04-12
4. Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption;Cancers;2024-01-04
5. Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer’s disease;Biomedicine & Pharmacotherapy;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3